I am removing the income position in chemical and agriculture technology company E.I. DuPont & Co. (NYSE: DD – $64.47) today. The price action has been disappointing of late and I do not see any near-term catalysts to drive the stock higher. The shares have languished ever since the company won a proxy battle with Nelson Petz’s Trian and appear to be overvalued at this point. The company is in the process of distributing its Chemours unit to shareholders, but – here again – the spin-off is not looking too promising for investors. I will take the nearly 48% profit (adjusted for the Chemours distribution) in DuPont and look for better income alternatives for the portfolio.